Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia.

J Exp Med · 2018 · PMC5789417 · PMID 29301866

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Consistently, high CD49d expression, the presence of TP53 disruption, and UM IGHV gene status (which did not reach statistical significance) identified a patient subset with shorter PFS intervals in the context of the RR cohort ( Fig. 7, G–I ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.